Dr. Alankrita Taneja, MD

Dr. Taneja practices at Jefferson Einstein Philadelphia Hospital in Philadelphia, Pennsylvania, part of Thomas Jefferson University.

Dr. Taneja's NPI, 1346746773, was assigned on April 4, 2018. Dr. Taneja holds Pennsylvania license MD485439.

Dr. Taneja's primary practice is Jefferson Einstein Philadelphia Hospital, at 5501 Old York Road, Philadelphia, PA 19141 in Philadelphia County. The practice phone is (215) 456-6090.

Dr. Taneja's primary practice is Jefferson Einstein Philadelphia Hospital in Philadelphia, Pennsylvania, part of Thomas Jefferson University. Dr. Taneja is also affiliated with Thomas Jefferson University Hospital. The medical group on file is Einstein Gastroenterology Associates. Dmand AI also links Dr. Taneja to 1 more dialysis center, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Taneja practices, 3 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Taneja's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Taneja is licensed in Pennsylvania.

CMS data shows 14 Medicare services from Dr. Taneja across 1 procedure code in 2024, for 33 Medicare patients. Medicare paid $1,370 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 33 Medicare patients who saw Dr. Taneja in 2024. The largest group is 65 to 74, with 14 patients. 75% of them have high blood pressure, and 73% have high cholesterol. 55% are also on Medicaid. Their average risk score is 4.35, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Taneja's median patient age at 61, with 60% women.

In 2024, Dr. Taneja wrote 25 Medicare Part D claims. 84% of them were for generic drugs. They cover 4 drugs, with $1,985 in total drug cost. In 2021, CMS named 86 claims across 4 drugs.

Dr. Taneja accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 10 papers to Dr. Taneja, published from 2017 to 2023. 2018 was the busiest year, with 3. The most frequent topics are India, Leukemia, Lymphocytic, Chronic, B-Cell and Life. Dr. Taneja has published most often in Eur J Haematol. Dr. Taneja's most frequent co-authors are Inhye Ahn, MD, Shebli Atrash, MD and Nitya Bakshi, MD.

CMS Open Payments shows 14 general payments to Dr. Taneja from 7 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 77% of the total. Janssen Pharmaceuticals, Inc paid the most, $244.